H3N2 Super Flu Alert: Key Symptoms to Spot This Winter Season!

MEXICO CITY (apro).— The spread of the influenza A H3N2 virus, including subtype K, has seen a rise during the 2025-2026 winter season across various regions, including Latin America, the United States, and Europe. International health authorities have reported a rising trend of the virus and have urged the public to bolster their annual flu vaccinations as a control measure.

The Pan American Health Organization (PAHO) has noted that subtype K has been identified in several countries and has called for enhanced virological surveillance. Although the virus is still classified as seasonal influenza, its rapid spread has led to calls for intensified immunization campaigns, particularly among vulnerable populations.

Analysis, context, and facts. Click and follow us on Google News

In Mexico, the National Institute of Respiratory Diseases (INER) confirmed a case of influenza A H3N2 subtype K in a patient who was treated with antiviral medication and showed favorable progress. The Health Ministry reported ongoing epidemiological monitoring and has increased the distribution of vaccines in medical units due to the heightened virus circulation.

Identifying Symptoms of Influenza and Differentiation from a Common Cold

The symptoms of influenza A H3N2 share some similarities with those of a common cold, but are distinguished by their sudden onset and greater severity, allowing for more accurate identification. Clinical reports and surveillance guidelines list common symptoms as:

• Sudden onset of high fever.
• Persistent dry cough that can last for several days.
• Sore throat and nasal congestion.
• Headache and widespread muscle pain.
• Significant fatigue from the early stages of the illness.
• Chills and sweating at the onset of the illness.

Experts point out that colds typically begin gradually, with mild discomfort, sneezing, and predominantly nasal congestion. In contrast, influenza starts with a high fever and significantly impacts the ability to perform daily activities.

Distinguishing between the two is crucial to avoid delays in treatment, especially when risk factors are present or signs of severity are detected.

Signs that Require Immediate Medical Attention

While most cases of influenza can be managed with rest, hydration, and symptom control, certain signs warrant timely medical evaluation due to the risk of respiratory complications:

• Breathing difficulties or shortness of breath.
• Persistent chest pain or pressure.
• Severe dizziness, confusion, or unusual sleepiness.
• Worsening of pre-existing medical conditions.
• Rapidly progressing weakness.

Individuals most likely to develop complications include older adults, children under five years, pregnant women, and those with chronic diseases. In these cases, early use of antivirals can shorten the duration of illness and reduce the risk of hospitalization.

Diagnosis and Recommended Measures to Prevent Transmission

Influenza is primarily transmitted through respiratory droplets when coughing, sneezing, or talking. Diagnosis is confirmed through laboratory tests like PCR or rapid antigen tests, which help distinguish it from other circulating respiratory viruses.

Health authorities continue to recommend receiving the annual influenza vaccine. The seasonal formulation targets A(H1N1) and A(H3N2) subtypes, as well as influenza B. Although effectiveness may vary, vaccination significantly reduces the risk of severe illness and hospitalization.

Additional measures to reduce transmission include:

• Frequent hand washing with soap and water.
• Covering nose and mouth when coughing or sneezing.
• Avoiding close contact with sick individuals.
• Staying home during the contagious period.
• International monitoring of the virus’s behavior

Global organizations continue to analyze the evolution of the A H3N2 subtype and its impact on the current season. The WHO and PAHO are monitoring transmission patterns to adjust health recommendations and update information for health systems. Surveillance helps identify genetic changes, assess vaccine effectiveness, and guide preventive actions in the region.